Antemortem Heparin in Organ Donation After Circulatory Death Determination: A Systematic Review of the Literature
暂无分享,去创建一个
G. Guyatt | M. Meade | B. Rochwerg | I. Ball | F. D’Aragon | E. Belley‐Cote | A. Şener | F. Foroutan | M. Selzner | F. Alshamsi | K. Honarmand | Graham Mclure
[1] M. Meade,et al. Variability in deceased donor care in Canada: a report of the Canada-DONATE cohort study , 2020, Canadian Journal of Anesthesia/Journal canadien d'anesthésie.
[2] J. Ijzermans,et al. Donor hepatectomy time influences ischemia-reperfusion injury of the biliary tree in donation after circulatory death liver transplantation. , 2020, Surgery.
[3] G. Isac,et al. Donation after circulatory determination of death in western Canada: a multicentre study of donor characteristics and critical care practices , 2020, Canadian Journal of Anesthesia/Journal canadien d'anesthésie.
[4] J. Cifrián,et al. Combined lung and liver procurement in controlled donation after circulatory death using normothermic abdominal perfusion. Initial experience in two Spanish centers , 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[5] S. Pértega,et al. Results in liver transplantation using grafts from donors after controlled circulatory death: A single‐center experience comparing donor grafts harvested after controlled circulatory death to those harvested after brain death , 2019, Clinical transplantation.
[6] Lunxu Liu,et al. The comparable efficacy of lung donation after circulatory death and brain death: a systematic review and meta-analysis. , 2019, Transplantation.
[7] K. Noyes,et al. Transplant Outcomes of Donation After Circulatory Death Livers Recovered With Versus Without Premortem Heparin Administration , 2019, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[8] M. Nijsten,et al. Transplantation of High-risk Donor Livers After Ex Situ Resuscitation and Assessment Using Combined Hypo- and Normothermic Machine Perfusion: A Prospective Clinical Trial. , 2019, Annals of surgery.
[9] N. Chalasani,et al. Expanding the Donor Pool With the Use of Extended Criteria Donation After Circulatory Death Livers , 2019, Liver Transplantation.
[10] K. Noyes,et al. Outcomes of DCD kidneys recovered for transplantation with versus without pre‐mortem heparin administration , 2019, Clinical transplantation.
[11] J. Neuberger,et al. Survival advantage for patients accepting the offer of a circulatory death liver transplant. , 2019, Journal of hepatology.
[12] J. Pijoan,et al. Favorable Outcomes After Liver Transplantation With Normothermic Regional Perfusion From Donors After Circulatory Death: A Single-center Experience , 2019, Transplantation.
[13] M. Perera,et al. Retrieval Practice or Overall Donor and Recipient Risk: What Impacts on Outcomes After Donation After Circulatory Death Liver Transplantation in the United Kingdom? , 2019, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[14] B. Ericzon,et al. Simultaneous Pancreas-Kidney Transplant From Donors After Brain Death vs Donors After Circulatory Death: A Single-Center Follow-up Study Over 3 Decades. , 2019, Transplantation proceedings.
[15] D. Vijayanand,et al. Impact of Donor Hepatectomy Time During Organ Procurement in Donation After Circulatory Death Liver Transplantation: The United Kingdom Experience , 2019, Transplantation.
[16] I. Al Hasan,et al. Can we reduce ischemic cholangiopathy rates in donation after cardiac death liver transplantation after 10 years of practice? Canadian single-centre experience , 2019, Canadian journal of surgery. Journal canadien de chirurgie.
[17] C. Benden,et al. Lung Transplantation with Controlled Donation after Circulatory Death Donors , 2018, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.
[18] S. McCluskey,et al. Expanding the donor pool: Donation after circulatory death and living liver donation do not compromise the results of liver transplantation , 2018, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[19] C. Fondevila,et al. Heparin but not tissue plasminogen activator improves outcomes in donation after circulatory death liver transplantation in a porcine model , 2018, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[20] W. Chapman,et al. The influence of functional warm ischemia time on DCD liver transplant recipients’ outcomes , 2017, Clinical transplantation.
[21] P. V. D. van der Boog,et al. Pancreas Transplantation With Grafts From Donors Deceased After Circulatory Death: 5 Years Single-Center Experience , 2017, Transplantation.
[22] Adam M. Kressel,et al. Safety and Outcomes in 100 Consecutive Donation After Circulatory Death Liver Transplants Using a Protocol That Includes Thrombolytic Therapy , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[23] J. Rubio,et al. Validation of a new proposal to avoid donor resuscitation in controlled donation after circulatory death with normothermic regional perfusion. , 2017, Resuscitation.
[24] C. Doig,et al. Premortem Heparin Administration and Location of Withdrawal of Life-Sustaining Interventions in DCD: Lack of High-Quality Evidence Precludes Definitive Conclusions. , 2016, Transplantation.
[25] C. Kubal,et al. Optimization of Perioperative Conditions to Prevent Ischemic Cholangiopathy in Donation After Circulatory Death Donor Liver Transplantation , 2016, Transplantation.
[26] H. Opdam,et al. Organ Donation after Circulatory Death in a University Teaching Hospital , 2016, Anaesthesia and intensive care.
[27] P. Macdonald,et al. Donation After Circulatory Death for Liver Transplantation: A Meta-Analysis on the Location of Life Support Withdrawal Affecting Outcomes , 2016, Transplantation.
[28] C. Dunham,et al. Donor preoperative oxygen delivery and post-extubation hypoxia impact donation after circulatory death hypoxic cholangiopathy. , 2016, World journal of gastroenterology.
[29] R. Porte,et al. Pre-transplant portal vein thrombosis is an independent risk factor for graft loss due to hepatic artery thrombosis in liver transplant recipients. , 2016, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[30] M. B. Allen,et al. Donor Hemodynamics as a Predictor of Outcomes After Kidney Transplantation From Donors After Cardiac Death , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[31] Charles M. Miller,et al. Impact of donor age in liver transplantation from donation after circulatory death donors: A decade of experience at Cleveland Clinic , 2015, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[32] J. Fung,et al. Enhancing kidney function with thrombolytic therapy following donation after cardiac death: a multicenter quasi‐blinded prospective randomized trial , 2015, Clinical transplantation.
[33] L. Kamal,et al. Outcomes of Kidney Transplant Recipients From Donation After Circulatory Death Donors Without Preagonal Heparin Administration. , 2015, Transplantation.
[34] W. Chapman,et al. Outcomes Using Grafts from Donors after Cardiac Death. , 2015, Journal of the American College of Surgeons.
[35] Min Zhang,et al. Donation after cardiac death liver transplantation: Graft quality evaluation based on pretransplant liver biopsy , 2015, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[36] S. Keshavjee,et al. Lung Transplantation With Donation After Circulatory Determination of Death Donors and the Impact of Ex Vivo Lung Perfusion , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[37] R. Love,et al. Donation after circulatory death: the current state and technical approaches to organ procurement , 2015, Current opinion in organ transplantation.
[38] J. Reyes,et al. Differential Rates of Ischemic Cholangiopathy and Graft Survival Associated With Induction Therapy in DCD Liver Transplantation , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[39] G. Oniscu,et al. In Situ Normothermic Regional Perfusion for Controlled Donation After Circulatory Death—The United Kingdom Experience , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[40] Qiang Zhao,et al. Liver transplantation using organs from deceased organ donors: a single organ transplant center experience. , 2014, Hepatobiliary & pancreatic diseases international : HBPD INT.
[41] T. Gonwa,et al. Inferior long‐term outcomes of liver‐kidney transplantation using donation after cardiac death donors: Single‐center and organ procurement and transplantation network analyses , 2014, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[42] M. Meurisse,et al. Donor age as a risk factor in donation after circulatory death liver transplantation in a controlled withdrawal protocol programme , 2014, The British journal of surgery.
[43] M. Bacchetta,et al. Lung Transplantation Using Allografts From Donation After Cardiac Death Donors , 2014 .
[44] J. Praestgaard,et al. Donor hemodynamic profile presages graft survival in donation after cardiac death liver transplantation , 2014, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[45] P. Gow,et al. Predictors of early graft loss in donation after circulatory death liver transplantation. , 2013 .
[46] S. Halpern,et al. An official American Thoracic Society/International Society for Heart and Lung Transplantation/Society of Critical Care Medicine/Association of Organ and Procurement Organizations/United Network of Organ Sharing Statement: ethical and policy considerations in organ donation after circulatory determi , 2013, American journal of respiratory and critical care medicine.
[47] Stephen J. Gentles,et al. The GRADE approach is reproducible in assessing the quality of evidence of quantitative evidence syntheses. , 2013, Journal of clinical epidemiology.
[48] H. Trivedi,et al. Outcome of renal transplantation from deceased donors after cardiac death: a single-center experience from a developing country. , 2013, Transplantation proceedings.
[49] D. Hathaway,et al. Liver transplant using donors after cardiac death: a single-center approach providing outcomes comparable to donation after brain death. , 2013, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation.
[50] B. Griffith,et al. Ex Vivo Lung Evaluation of Prearrest Heparinization in Donation After Cardiac Death , 2013, Annals of surgery.
[51] G. Dellgren,et al. Heparin does not improve graft function in uncontrolled non-heart-beating lung donation: an experimental study in pigs. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[52] Elie A Akl,et al. GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes. , 2013, Journal of clinical epidemiology.
[53] G. Snell,et al. Excellent Clinical Outcomes From a National Donation‐After‐Determination‐of‐Cardiac‐Death Lung Transplant Collaborative , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[54] S. Fuggle,et al. Pancreas Transplantation From Donors After Circulatory Death From the United Kingdom , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[55] J. Nguyen,et al. Asystole to cross‐clamp period predicts development of biliary complications in liver transplantation using donation after cardiac death donors , 2012, Transplant international : official journal of the European Society for Organ Transplantation.
[56] N. Biller-Andorno,et al. Whose consent matters? Controlled donation after cardiac death and premortem organ-preserving measures. , 2012, Transplantation.
[57] J. Squifflet,et al. Results of kidney transplantation from controlled donors after cardio‐circulatory death: a single center experience , 2012, Transplant international : official journal of the European Society for Organ Transplantation.
[58] R. Truog,et al. Donation after Circulatory Determination of Death , 2011 .
[59] H. Sollinger,et al. Donation after cardiac death: a 29-year experience. , 2011, Surgery.
[60] Johnny C. Hong,et al. Liver transplantation using organ donation after cardiac death: a clinical predictive index for graft failure-free survival. , 2011, Archives of surgery.
[61] Scott R. Johnson,et al. Minimising cold ischaemic time is essential in cardiac death donor-associated liver transplantation. , 2011, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[62] S. Keshavjee,et al. Organ donation after cardiac death: donor and recipient outcomes after the first three years of the Ontario experience , 2011, Canadian journal of anaesthesia = Journal canadien d'anesthesie.
[63] R. Stratta,et al. Lessons learned from a single center's experience with 134 donation after cardiac death donor kidney transplants. , 2011, Journal of the American College of Surgeons.
[64] H. Sollinger,et al. Biliary Complications After Liver Transplantation From Donation After Cardiac Death Donors: An Analysis of Risk Factors and Long-term Outcomes From a Single Center , 2011, Annals of surgery.
[65] Howard Balshem,et al. GRADE guidelines: 3. Rating the quality of evidence. , 2011, Journal of clinical epidemiology.
[66] F. Nevens,et al. LIVER TRANSPLANTATION FROM DONATION AFTER CARDIOCIRCULATORY DEATH (DCD) DONORS: BELGIAN EXPERIENCE 2003-2009 , 2011 .
[67] P. Marotta,et al. The clinical consequences of utilizing donation after cardiac death liver grafts into hepatitis C recipients , 2011, Hepatology international.
[68] F. Aucejo,et al. Use of Tissue Plasminogen Activator in Liver Transplantation from Donation After Cardiac Death Donors , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[69] S. Sano,et al. Post-mortem tissue-type plasminogen activator preserves graft function of hearts harvested from non-pre-treated non-heart-beating donors. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[70] E. Verschuuren,et al. The use of non-heart-beating lung donors category III can increase the donor pool. , 2010, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[71] S. Yamamoto,et al. Liver Transplantation with Grafts from Controlled Donors after Cardiac Death: A 20‐Year Follow‐up at a Single Center , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[72] O. Ciccarelli,et al. Liver transplantation from donation after cardiac death donors: initial Belgian experience 2003–2007 , 2009, Transplant international : official journal of the European Society for Organ Transplantation.
[73] J. Feinglass,et al. The impact of ischemic cholangiopathy in liver transplantation using donors after cardiac death: the untold story. , 2009, Surgery.
[74] A. Demetris,et al. Liver Transplantation Using Donation After Cardiac Death Donors: Long‐Term Follow‐Up from a Single Center , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[75] J. Herget,et al. Pre-arrest administration of the cell-permeable free radical scavenger tempol reduces warm ischemic damage of lung function in non-heart-beating donors. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[76] J. Reyes,et al. Ischemic cholangiopathy following liver transplantation from donation after cardiac death donors , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[77] Anurag Maheshwari,et al. Biliary complications and outcomes of liver transplantation from donors after cardiac death , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[78] Y. Becker,et al. Donation After Cardiac Death: The University of Wisconsin Experience With Liver Transplantation , 2005, Annals of surgery.
[79] E. D. Motta. The ethics of heparin administration to the potential non-heart-beating organ donor. , 2005, Journal of professional nursing : official journal of the American Association of Colleges of Nursing.
[80] N. Polissar,et al. Livers transplanted from donors after cardiac death occurring in the ICU or the operating room have excellent outcomes. , 2005, Transplantation proceedings.
[81] N. Soomro,et al. Do tissue damage biomarkers used to assess machine-perfused NHBD kidneys predict long-term renal function post-transplant? , 2003, Clinica chimica acta; international journal of clinical chemistry.
[82] K. Olthoff,et al. Liver transplantation from controlled non–heart-beating donors: an increased incidence of biliary complications , 2003, Transplantation.
[83] P. Muiesan. Liver Transplantation From Controlled Non???Heart-Beating Donors: An Increased Incidence of Biliary Complications. , 2003 .
[84] H. Schäfers,et al. Heparin and the nonanticoagulant N-acetyl heparin attenuate capillary no-reflow after normothermic ischemia of the lung. , 2001, The Annals of thoracic surgery.
[85] S. Fujimi,et al. Multivariate analyses of factors contributing to early graft function in 759 kidney transplants from non-heart-beating donors. , 2001, Transplantation proceedings.
[86] C. Smee,et al. United Kingdom , 2000, International Journal of Pharmaceutical Medicine.
[87] M. Menger,et al. Heparin and phentolamine combined, rather than heparin alone, improves hepatic microvascular procurement in a non‐heart‐beating donor rat‐model , 2000, Transplant international : official journal of the European Society for Organ Transplantation.
[88] M. Morandini,et al. Pre-arrest heparinization and ventilation during warm ischemia preserves lung function in non-heart-beating donors. , 1999, Journal of pediatric surgery.
[89] T. Starzl,et al. Liver and kidney transplantation from non-heart beating donors: the Pittsburgh experience. , 1995, Transplantation proceedings.
[90] M. Shinoda,et al. Clinical application of in situ renal cooling: experience with 61 cardiac-arrest donors. , 1989, Transplantation proceedings.
[91] David A. Beety. The United Kingdom Experience , 1977, Air and Space Law.
[92] F. D'Ovidio,et al. Use of Lung Allografts From Donation After Cardiac Death Donors: A Single-Center Experience. , 2018, The Annals of thoracic surgery.
[93] A. Webster,et al. Outcomes From Pancreatic Transplantation in Donation After Cardiac Death: A Systematic Review and Meta-Analysis , 2017, Transplantation.
[94] P. Tugwell,et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .
[95] E. Young. The anti-inflammatory effects of heparin and related compounds. , 2008, Thrombosis research.
[96] G. Knoll,et al. National recommendations for donation after cardiocirculatory death in Canada: Donation after cardiocirculatory death in Canada. , 2006, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.